2019
DOI: 10.4081/audiores.2019.230
|View full text |Cite
|
Sign up to set email alerts
|

Computational analysis based on audioprofiles: A new possibility for patient stratification in office-based otology

Abstract: Genetic contribution to progressive hearing loss in adults is underestimated. Established machine learning-based software could offer a rapid supportive tool to stratify patients with progressive hearing loss. A retrospective longitudinal analysis of 141 adult patients presenting with hearing loss was performed. Hearing threshold was measured at least twice 18 months or more apart. Based on the baseline audiogram, hearing thresholds and age were uploaded to AudioGene v4® (Center for Bioinformatics and Computat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 28 publications
0
6
0
Order By: Relevance
“…Weininger et al. used the AudioGene tool to stratify 141 patients with progressive hearing loss [36] . However, this tool, which was developed in 2008, is a product of the low development and high cost of gene sequencing instruments.…”
Section: Discussionmentioning
confidence: 99%
“…Weininger et al. used the AudioGene tool to stratify 141 patients with progressive hearing loss [36] . However, this tool, which was developed in 2008, is a product of the low development and high cost of gene sequencing instruments.…”
Section: Discussionmentioning
confidence: 99%
“…In voice-based analysis, AI is used to evaluate pathological voice conditions associated with vocal fold disorders, to analyze and decode phonation itself [67], to improve speech perception in noisy conditions, and to improve the hearing of pa-tients with CIs. In medical device-based analyses, AI is used to evaluate tissue and blood test results, as well as the outcomes of otorhinolaryngology-specific tests (e.g., polysomnography) [72,73,122] and audiometry [123,124]. AI has also been used to support clinical diagnoses and treatments, decision-making, the Table 4.…”
Section: Discussionmentioning
confidence: 99%
“…In voice-based analysis, AI is used to evaluate pathological voice conditions associated with vocal fold disorders, to analyze and decode phonation itself [ 67 ], to improve speech perception in noisy conditions, and to improve the hearing of patients with CIs. In medical device-based analyses, AI is used to evaluate tissue and blood test results, as well as the outcomes of otorhinolaryngology-specific tests (e.g., polysomnography) [ 72 , 73 , 122 ] and audiometry [ 123 , 124 ]. AI has also been used to support clinical diagnoses and treatments, decision-making, the prediction of prognoses [ 98 - 100 , 125 , 126 ], disease profiling, the construction of mass spectral databases [ 43 , 127 - 129 ], the identification or prediction of disease progress [ 101 , 105 , 107 - 110 , 130 ], and the confirmation of diagnoses and the utility of treatments [ 102 - 104 , 112 , 131 ].…”
Section: Discussionmentioning
confidence: 99%
“…As the CART, C5.0, and RF decision tree models involve stratifying or segmenting the predictor space into a number of nonoverlapping regions [ 38 ], recursive binary splitting for classification via the Gini index was performed [ 45 ]. Many of these decision tree types have been applied to audiological data, and they were found to provide good results in previous studies [ 20 - 24 ].…”
Section: Methodsmentioning
confidence: 99%
“…In the last 2 decades, various artificial intelligence and machine learning techniques have been developed and applied to hearing health data. Such approaches have mainly been used for disease profiling, although some studies have focused on the prediction of treatment outcomes [ 20 - 24 ]. It is noteworthy that the intervention trials in audiology and tinnitus research usually involve a few hundred participants and the collection of generally extensive data regarding demographic characteristics and clinical variables.…”
Section: Introductionmentioning
confidence: 99%